To support implementation of the mobile phone survey (MPS) in Casablanca and Mumbai. An extension of the Bloomberg Philanthropies Data for Health initiative.

To evaluate the feasibility, impact and safety of RTS,S/AS01E malaria vaccine implementation through routine health systems in moderate to high malaria transmission settings in sub-Saharan Africa.

To assess the acceptability, safety, feasibility and cost of a Typhoid Conjugate Vaccine (TCV) delivered as part of a ministry-led campaign in Harare, Zimbabwe. This evaluation will provide lessons learned and recommendations for future use of TCV in outbreak settings, and to inform typhoid control strategies.

To strengthen laboratory surveillance for pneumococcal meningitis and serotyping in India to understand the impact of a pneumococcal conjugate vaccine rollout.

To assist countries with developing costed, funded plans that address the gaps identified by the World Health Organization-led Joint External Evaluation (JEE) process, with the goal of helping countries reach compliance with the International Health Regulations. The CDC Foundation and CDC will support eight countries as they develop draft costed plans and help them identify funding to implement the plans.

To strengthen the global evidence base of the management of cardiovascular diseases; improve point-of-care testing; and monitor trends within the global noncommunicable disease burden.

To implement a two-phased approach to provide short and long-term solutions to the problem of inadequate water, sanitation and hygiene infrastructure in low-resource settings in Burkina Faso, Ethiopia, Ghana and Uganda.

To promote technical exchange through establishment and improvement of public health surveillance systems, laboratory testing and training to enhance public health initiatives related to cardiovascular disease.

To support cryopreservation and suppression of female development in mosquitoes to assist research for malaria control.

To conduct targeted assessments involving vaccine research and surveillance. The current studies range from a meningitis carriage study in Burkina Faso to measure the impact of the MenA vaccine, to rotavirus surveillance in Mozambique to look at vaccine effectiveness.